EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,330.00
+10.00 (0.16%)
At close: Dec 5, 2025
EASY BIO,Inc. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 465,243 | 384,331 | 165,385 | 155,557 | 129,458 | |
Revenue Growth (YoY) | 50.42% | 132.38% | 6.32% | 20.16% | - |
Cost of Revenue | 357,368 | 286,243 | 113,682 | 108,612 | 89,388 |
Gross Profit | 107,875 | 98,088 | 51,703 | 46,945 | 40,070 |
Selling, General & Admin | 58,609 | 56,931 | 27,710 | 26,952 | 20,575 |
Research & Development | 2,870 | 3,034 | 2,487 | 2,426 | 1,744 |
Amortization of Goodwill & Intangibles | 3,949 | 2,287 | 438.05 | 323.7 | 112.06 |
Other Operating Expenses | 2,219 | 2,140 | 268.54 | 217.04 | 167.89 |
Operating Expenses | 67,737 | 65,697 | 31,072 | 30,790 | 23,291 |
Operating Income | 40,138 | 32,391 | 20,631 | 16,155 | 16,779 |
Interest Expense | -8,650 | -9,025 | -3,219 | -1,720 | -1,105 |
Interest & Investment Income | 3,012 | 3,299 | 1,333 | 534.54 | 347.87 |
Currency Exchange Gain (Loss) | -530.35 | 2,558 | 981.1 | -1,670 | -160.27 |
Other Non Operating Income (Expenses) | -927.78 | -1,529 | -1,878 | -1,907 | -1,821 |
EBT Excluding Unusual Items | 33,042 | 27,696 | 17,848 | 11,392 | 14,041 |
Gain (Loss) on Sale of Investments | -119.66 | 1,035 | 2,224 | 592.15 | 12.04 |
Gain (Loss) on Sale of Assets | -126.96 | -114.65 | -7.04 | -0.33 | 0.9 |
Asset Writedown | -2,241 | -2,241 | - | - | - |
Pretax Income | 30,555 | 26,376 | 20,066 | 11,984 | 14,054 |
Income Tax Expense | 7,478 | 6,472 | 3,965 | 2,637 | 3,212 |
Earnings From Continuing Operations | 23,077 | 19,904 | 16,101 | 9,347 | 10,842 |
Minority Interest in Earnings | -1,072 | -299.18 | -557.26 | -216.61 | 30.73 |
Net Income | 22,005 | 19,604 | 15,544 | 9,131 | 10,873 |
Net Income to Common | 22,005 | 19,604 | 15,544 | 9,131 | 10,873 |
Net Income Growth | 10.10% | 26.12% | 70.24% | -16.02% | - |
Shares Outstanding (Basic) | 33 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 33 | 34 | 34 | 34 | 34 |
Shares Change (YoY) | -2.97% | -0.83% | - | 0.16% | - |
EPS (Basic) | 664.71 | 579.08 | 455.33 | 267.47 | 319.00 |
EPS (Diluted) | 664.63 | 579.00 | 455.00 | 267.00 | 319.00 |
EPS Growth | 13.61% | 27.25% | 70.41% | -16.30% | - |
Free Cash Flow | 25,960 | 21,510 | 31,798 | -10,079 | 12,231 |
Free Cash Flow Per Share | 784.20 | 635.37 | 931.49 | -295.24 | 358.86 |
Dividend Per Share | 200.000 | 200.000 | 100.000 | 75.000 | - |
Dividend Growth | 100.00% | 100.00% | 33.33% | - | - |
Gross Margin | 23.19% | 25.52% | 31.26% | 30.18% | 30.95% |
Operating Margin | 8.63% | 8.43% | 12.47% | 10.38% | 12.96% |
Profit Margin | 4.73% | 5.10% | 9.40% | 5.87% | 8.40% |
Free Cash Flow Margin | 5.58% | 5.60% | 19.23% | -6.48% | 9.45% |
EBITDA | 50,076 | 39,896 | 24,323 | 19,918 | 19,580 |
EBITDA Margin | 10.76% | 10.38% | 14.71% | 12.80% | 15.13% |
D&A For EBITDA | 9,938 | 7,505 | 3,692 | 3,763 | 2,801 |
EBIT | 40,138 | 32,391 | 20,631 | 16,155 | 16,779 |
EBIT Margin | 8.63% | 8.43% | 12.47% | 10.38% | 12.96% |
Effective Tax Rate | 24.47% | 24.54% | 19.76% | 22.00% | 22.86% |
Advertising Expenses | - | 873.74 | 830.48 | 690.36 | 342.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.